Peer Review #2 of "Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis (v0.2)"
peer-review
OA: gold
CC0
Abstract
Background.Guizhi Fuling Wan (GZFLW) is a widely used classical Chinese herbal formulae prescribed for the treatment of endometriosis (EMs).This study aimed to predict the key targets and mechanisms of GZFLW in the treatment of EMs by network pharmacology and molecular docking.Methods.Firstly, related compounds and targets of GZFLW were identified through the TCMSP, BATMAN-TCM and CASC Database.Then, the EMs target database was built by GeneCards.The overlapping targets between GZFLW and EMs were screened out, and then data of the PPI network was obtained by the String database to analyze the interrelationship of these targets.Furthermore, a topological analysis was performed to screen the hub targets.After that, molecular docking technology was used to confirm the binding degree of the main active compounds and hub targets.Finally, the DAVID database and Metascape database were used for GO and KEGG enrichment analysis.Results.A total of 89 GZFLW compounds and 284 targets were collected.One hundred one matching targets were picked out as the correlative targets of GZFLW in treating EMs.Among these, 25 significant hub targets were recognized by the PPI network.Coincidently, molecular docking simulation indicated that the hub targets had a good bonding activity with most active compounds (69.71%).Furthermore, 116 items, including the inflammatory reaction, RNA polymerase, DNA transcription, growth factor activity, and steroid-binding, were selected by GO enrichment analysis.Moreover, the KEGG enrichment analysis results included 100 pathways focused on the AGE-RAGE pathway, HIF pathway, PI3K Akt pathway, MAPK pathway, and TP53 pathway, which exposed the potential mechanisms of GZFLW in treating EMs.Conclusion.Through the exploration of network pharmacology and molecular docking technology, GZFLW has a therapeutic effect on EMs through multi-target mechanism.This study provided a good foundation for further experimental research.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (56)
- Altered Immunity in Endometriosis: What Came First? via openalex
- Association of TP53 codon 72 polymorphism in women suffering from endometriosis from Lahore, Pakistan. via openalex
- Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis via openalex
- Disrupted iron metabolism in peritoneal fluid may induce oxidative stress in the peritoneal cavity of women with endometriosis via openalex
- [DYSMENORRHEA - ITS PREVALENCE, CAUSES, INFLUENCE ON THE AFFECTED WOMEN AND POSSIBLE TREATMENTS]. via openalex
- EGFR‐mediated matrix metalloproteinase‐7 up‐regulation promotes epithelial‐mesenchymal transition <i>via</i> ERK1‐AP1 axis during ovarian endometriosis progression via openalex
- Endometriosis and adenomyosis are associated with increased risk of preterm delivery and a small‐for‐gestational‐age child: a systematic review and meta‐analysis via openalex
- Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis via openalex
- Health‐related quality of life in women with endometriosis, compared with the general population and women with rheumatoid arthritis via openalex
- Hypoxia: The force of endometriosis via openalex
- IL-1β Stimulates Brain-Derived Neurotrophic Factor Production in Eutopic Endometriosis Stromal Cell Cultures via openalex
- Immune-inflammation gene signatures in endometriosis patients via openalex
- miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells via openalex
- Novel dietary supplement association reduces symptoms in endometriosis patients via openalex
- Promising activity of Anthemis austriaca Jacq. on the endometriosis rat model and isolation of its active constituents via openalex
- Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo via openalex
- Satisfaction with medical support in women with endometriosis via openalex
- Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival via openalex
- The regression of endometriosis with glycosylated flavonoids isolated from Melilotus officinalis (L.) Pall. in an endometriosis rat model via openalex
- Understanding the Role of Gui‐Zhi‐Fu‐Ling‐Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics via openalex
- W2750509775 via openalex
- W2754235880 via openalex
- W2767555394 via openalex
- W1965581381 via openalex
- W2896694652 via openalex
- W2902578261 via openalex
- W2928665623 via openalex
- W2940198494 via openalex
- W2943544893 via openalex
- W2944801678 via openalex
- W2955603111 via openalex
- W2977249543 via openalex
- W2987136955 via openalex
- W2988476950 via openalex
- W3025829110 via openalex
- W6675471023 via openalex
- W2790667839 via openalex
- W2008277519 via openalex
- W2033591223 via openalex
- W2070603512 via openalex
- W2076804940 via openalex
- W2103017472 via openalex
- W2120565642 via openalex
- W2124679671 via openalex
- W2151155970 via openalex
- W2158217645 via openalex
- W2159482845 via openalex
- W2159675211 via openalex
- W2279201083 via openalex
- W2474747771 via openalex
- W2480824319 via openalex
- W2537623931 via openalex
- W2537730044 via openalex
- W2568852888 via openalex
- W2593253323 via openalex
- W2613451843 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK